SMTL ID : 3e51.2 (1 other biounit)

Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x N35: N-{3-[5-hydroxy-2-(3-methylbutyl)-3-oxo-6-pyrrolidin-1-yl-2,3-dihydropyridazin-4-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide(Non-covalent)

N35.1: 19 residues within 4Å: Chain A: F.193, R.200, S.288, N.291, N.316, G.317, D.318, C.366, S.368, L.384, G.410, N.411, M.414, Y.415, Q.446, I.447, Y.448, G.449, S.556 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.448, A:Y.448 Hydrogen bonds: A:N.291, A:D.318, A:D.318, A:Y.448 Water bridges: A:Y.415, A:G.449, A:G.449, A:S.556 pi-Stacking: A:F.193

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Dragovich, P.S. et al., Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents. Bioorg.Med.Chem.Lett. (2008)

Release Date

2009-08-18

Peptides

RNA-directed RNA polymerase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

RNA-directed RNA polymerase

Related Entries With Identical Sequence